Insider Sale: Director at $ZM Sells 2,617 Shares

Director Janet Napolitano sold 2,617 shares of $ZM on 06-13-2025 for approximately $200,921, representing 35.6% of their holdings; this sale is part of a broader trend of insider selling at $ZM, with executives like Eric Yuan selling substantial amounts over the past six months. Institutional investors displayed mixed sentiment in recent quarters, with Norges Bank and JPMorgan Chase increasing their positions significantly, while FMR LLC and Pacer Advisors reduced theirs. Wall Street analysts maintain a generally positive outlook, with Needham and Jefferies issuing "Buy" ratings and a median price target of $85.00.

Analysis

A director at $ZM, Janet Napolitano, recently divested a significant 35.6% of her holdings, selling 2,617 shares for approximately $200,921. This sale aligns with a broader, pronounced trend of insider selling at $ZM over the past six months, featuring 33 sales and zero purchases by insiders, highlighted by CEO Eric S. Yuan's disposition of 609,569 shares valued at an estimated $48.4 million. Such consistent selling by top executives often signals caution regarding a company's outlook. Institutional sentiment appears divided: while 360 institutions trimmed their $ZM positions in the most recent quarter, 367 increased theirs. Notably, Norges Bank significantly boosted its stake by 7.67 million shares (+495.4%) in Q4 2024, and JPMorgan Chase added 3.53 million shares (+181.0%) in Q1 2025, whereas FMR LLC and Pacer Advisors made substantial reductions. In contrast to insider disposals, Wall Street analysts maintain a positive outlook, with Needham and Jefferies issuing "Buy" ratings, and a median price target of $85.00 from three analysts, implying potential upside from the approximate $76.77 per share price of Napolitano's transaction. Congressional trading shows minor buying activity by one representative, totaling five purchases up to $75,000 in the last six months, which is of limited significance compared to the volume of insider sales.

Key Decisions for Investors

• Investors should exercise caution due to the significant and consistent pattern of insider selling at $ZM, including substantial sales by the CEO and other key executives, which may indicate internal concerns about the company's valuation or future growth prospects.
• The positive analyst ratings, with a median price target of $85.00, should be weighed carefully against the bearish sentiment implied by widespread insider disposals; further due diligence is warranted to understand this divergence.
• Monitor shifts in institutional holdings, particularly whether large recent buyers like Norges Bank and JPMorgan Chase maintain or increase their conviction, as this could provide a counter-signal to the prevailing insider selling trend and offer insights into institutional assessment of $ZM's long-term value.